AW

Anita Wiebe

IG Immatics Biotechnologies Gmbh: 74 patents #12 of 99Top 15%
📍 Rötteln, DE: #9 of 115 inventorsTop 8%
Overall (All Time): #26,021 of 4,157,543Top 1%
74
Patents All Time

Issued Patents All Time

Showing 1–25 of 74 patents

Patent #TitleCo-InventorsDate
12275775 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche +1 more 2025-04-15
12275776 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche +1 more 2025-04-15
12221468 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche +1 more 2025-02-11
12180256 Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers Oliver Schoor, Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2024-12-31
12150979 Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers Oliver Schoor, Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2024-11-26
12121572 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2024-10-22
12097248 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2024-09-24
12076380 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2024-09-03
12070491 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2024-08-27
12036271 Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2024-07-16
11897936 Peptides, combination of peptides as targets and for use in immunotherapy Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2024-02-13
11897935 Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2024-02-13
11786583 Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2023-10-17
11779638 Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2023-10-10
11679147 Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2023-06-20
11672848 Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2023-06-13
11597752 Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers Oliver Schoor, Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2023-03-07
11576956 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2023-02-14
11559573 Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2023-01-24
11406693 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2022-08-09
11260115 Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2022-03-01
11123370 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche +1 more 2021-09-21
11117951 Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2021-09-14
11083784 Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2021-08-10
11058726 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Colette Song, Oliver Schoor, Jens Fritsche +1 more 2021-07-13